|
此文章由 RR 原创或转贴,不代表本站立场和观点,版权归 oursteps.com.au 和作者 RR 所有!转贴必须注明作者、出处和本声明,并保持内容完整
Per FINA’s statement, as part of an in-competition doping control test on July 31, 2013, a sample from Palmer “showed low levels of a prohibited substance.” The statement also reveals that, per the request of FINA’s Doping Control Review Board (DCRB) two additional tests were performed in 2013, which both proved negative. As a result, in January 2014, the FINA DCRB recommended that “no further action was needed” and decided not to proceed with the case given the low levels detected of the prohibited substance, as well as the absence of the same substance (or any others) in the subsequent tests. The substance has still yet to be disclosed, although The Courier speculates the substance to be of the diuretic variety.
In a twist, however, in February of this year, the World Anti-Doping Association (WADA) requested that FINA provide documents specifically attributed to Palmer’s case. After reviewing such documents, WADA then decided to file an appeal with the Court of Arbitration of Sport (CAS) in Lausanne, requesting CAS to order FINA to “bring forward the July 31, 2013 findings as an anti-doping rule violation in accordance with DC 7.1.3.” This led to FINA’s notifying Palmer and Swimming Australia of the positive test from 2013 and Palmer’s subsequent acceptance of the voluntary provisional suspension. Note – copy of DC 7.1.3 direct from FINA’s Doping Control Rules is provided in its entirety at the end of this article.
|
|